NuGen Medical Devices Inc. NGMD.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 78.94% | 68.24% | -175.10% | 19.43% | -254.19% |
| Total Depreciation and Amortization | -178.09% | -15.40% | 16.57% | 3.97% | 7.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -235.24% | -89.24% | 466.33% | -47.51% | 159.78% |
| Change in Net Operating Assets | -543.08% | 126.97% | 3.98% | -176.76% | 152.83% |
| Cash from Operations | -12.66% | -4.30% | 7.96% | -49.14% | 10.12% |
| Capital Expenditure | 199.12% | -73.64% | -128.15% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -325.19% | -19,350.00% | 75.00% | 97.91% | -- |
| Cash from Investing | 119.33% | -104.48% | -125.23% | -44.91% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.40% | -19.38% | -1.06% | -48.88% | -4.25% |